Answers are grounded in this paper and cite their sources.
Review highlights recent advancements in immunotherapy and emerging strategies in lung cancer treatment, emphasizing personalized approaches.
Lung cancer is one of the leading causes of cancer worldwide, representing a major global health challenges. This review focuses on recent advancements in the treatment of lung cancer, with particular emphasis on immunotheraphy and emerging therapeutic strategies. In recent years, how immunotheraphy have transformed lung cancer management by enhancing the body immune response against tumor cells. Emerging approaches, including cancer vaccines, CAR-T cell therapy, oncolytic viruses, are currently being explored to overcome these limitations and improve treatment outcomes. Overall continued research and the development of personalised treatment strategies are essential for improving survival rate and achieving better clinical outcomes in lung cancer patients.
No takes yet. Share an insight, caveat, or question.
Gourav Kumar Gourav (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: